Epivir (Lamivudine) — Patient Information (UK)

Epivir contains lamivudine, a medicine used to treat certain viral infections, most commonly HIV and hepatitis B. This page explains how it works, how it is taken, and what to consider for safe use in the United Kingdom.

Always follow the advice of your healthcare professional. Information below is intended to help you understand the medicine and how to use it safely.

Basic product information

How Epivir works (mechanism of action)

Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI). It works by interfering with the virus’s ability to copy its genetic material.

In simplified terms:

• For HIV, lamivudine is incorporated into the virus’s DNA during replication. This blocks the normal building of the viral DNA strand, slowing viral growth.
• For hepatitis B, lamivudine similarly blocks steps required for the virus to reproduce.

Epivir is most effective when used as part of a planned treatment strategy, tailored to the virus and your overall care. Using it correctly helps reduce the risk of resistance.

Pharmacokinetics (how your body processes it)

Pharmacokinetics describes what happens after you take lamivudine—absorption, distribution, metabolism, and excretion.

• Absorption: Lamivudine is generally absorbed after oral dosing. Taking it with food does not significantly change overall absorption for most people.
• Distribution: It distributes throughout the body, including into tissues affected by viral infections.
• Metabolism: Lamivudine is not extensively metabolised by the liver.
• Elimination: The medicine is mainly cleared by the kidneys. If you have reduced kidney function, your prescriber may adjust the dose.
• Half-life: Lamivudine has a duration that supports dosing schedules commonly used in HIV and hepatitis B treatment plans.

If you have kidney disease, have previously been told you have impaired kidney function, or are taking medicines that affect the kidneys, it is important to discuss dose suitability and monitoring.

Typical use in the UK

In the UK, lamivudine is used for two main areas of viral disease:

• HIV infection: Epivir is used as part of combination antiretroviral therapy to reduce viral load. Combination therapy helps prevent resistance.
• Chronic hepatitis B: Lamivudine may be used in selected patients with ongoing hepatitis B infection. Long-term use of nucleoside/nucleotide analogues can be complicated by resistance patterns, so clinicians may choose particular agents based on your situation and guidance.

Timing and how to take Epivir

The best timing depends on the specific regimen you are following and the condition being treated. In general:

• Consistency is key: Try to take your dose at the same times each day.
• If taking twice daily: Space doses roughly evenly (for example morning and evening).
• If taking once daily: Choose a time you can reliably remember.
• What if you miss a dose? Take it when you remember unless it is close to the time of the next dose. Do not take a double dose to make up for a missed tablet/syrup.
• Stopping treatment: Do not stop abruptly without advice. In hepatitis B, stopping can lead to a flare of liver disease. In HIV, stopping or changing regimens without guidance can risk viral rebound.

If you are unsure about your schedule, check the label on your medicine and the instructions provided by your prescriber or pharmacist.

Food interactions

Epivir can usually be taken with or without food. Food does not typically make a clinically important difference to how much lamivudine your body absorbs.

Practical tips:

• If you find tablets easier with meals, you may take them with breakfast or dinner.
• Keep an eye on how you feel—if you get stomach upset, taking with food may help.
• If you use the oral solution, follow the dosing device instructions and measure accurately.

Alcohol and medicine interactions

There is no specific “direct” interaction between lamivudine and alcohol that typically makes alcohol unsafe in all people. However, alcohol can affect the liver and overall health, which is especially relevant if you are taking Epivir for hepatitis B.

• Hepatitis B: Alcohol may increase the risk of liver irritation and can worsen liver outcomes. Consider limiting or avoiding alcohol, and ask your healthcare professional for personalised advice.
• HIV: Alcohol can interact with other medicines in your regimen and may affect adherence. If you drink, aim for moderation and avoid missing doses.
• General safety: If you develop unusual fatigue, yellowing of the skin/eyes, dark urine, or right-sided abdominal pain, seek medical advice promptly.

Medication interactions (important)

Lamivudine is eliminated mainly by the kidneys. This matters for potential interactions with medicines that affect renal clearance.

Tell your pharmacist or healthcare professional if you take:

• Medicines that may affect kidney function (for example, some antibiotics or anti-inflammatory drugs taken regularly)
• Other medicines used for HIV or hepatitis B (to ensure compatibility within the overall regimen)
• Medicines that contain similar active substances (to avoid duplicating therapy)
• Herbal products or supplements, including those marketed for “immune support”

A full interaction check is best done by your clinician or pharmacist because your exact regimen matters. If you are starting a new medicine, it is wise to confirm there are no issues.

Indications (what Epivir is used for)

Epivir is indicated for:

• HIV-1 infection as part of combination antiretroviral therapy.
• Chronic hepatitis B in appropriate patients, as determined by your specialist based on disease severity and treatment plan.

The choice of whether lamivudine is appropriate—and whether another antiviral is preferred—depends on national guidance, your viral resistance profile (if known), liver/kidney function, and other medicines you take.

Dosing information (general guidance)

Dosing must be individualised. The dose you receive will depend on the condition being treated and your kidney function. Use the dosing instructions on your medicine label and the advice you have been given.

Typical dosing principles

• Adults: Lamivudine dosing differs between HIV and hepatitis B and may vary with regimen.
• Children: Doses may be weight-based and may require the oral solution.
• Kidney impairment: Dosing may be reduced. Kidney function is usually monitored during treatment.
• Duration: HIV treatment is typically long-term. Hepatitis B treatment may be long-term depending on response.

Do not adjust your dose without medical advice, particularly if you have kidney disease.

Dose timing examples (illustrative)

These examples may not match your exact regimen. They are here to explain how to space doses:

• Twice daily: Take one dose in the morning and one in the evening, about 12 hours apart.
• Once daily: Take at the same time each day (for example, with breakfast or at bedtime).

Safety profile: what to watch for

Like all medicines, Epivir can cause side effects. Many people experience mild effects, but some require prompt medical attention.

Common side effects

• Nausea or stomach upset
• Headache
• Fatigue
• Diarrhoea
• Changes in blood test results (for example, certain liver-related or blood cell parameters)

Serious side effects (seek medical advice urgently)

Contact a healthcare professional urgently or seek emergency help if you experience signs of serious reactions such as:

• Allergic reaction: swelling of the face/lips, rash, difficulty breathing, or severe dizziness
• Liver problems: yellowing of the skin/eyes (jaundice), severe abdominal pain, persistent vomiting, or dark urine (especially important if you have hepatitis B)
• Lactic acidosis (rare, but serious): unusual tiredness, rapid breathing, persistent nausea/vomiting, abdominal pain, or feeling very unwell—particularly if on combination HIV therapy
• Worsening infection control: changes in symptoms, fever, or feeling progressively unwell (in HIV treatment, viral control depends on adherence and regimen strength)

Long-term safety considerations

• Blood and kidney monitoring: Your clinician may monitor kidney function and blood counts at intervals.
• Hepatitis B flare risk: If you have hepatitis B and treatment stops, the virus may reactivate and cause liver inflammation. Monitoring after stopping is important.
• Resistance: Over time, some viruses develop resistance. Your clinician may use viral load testing and treatment reviews to manage this.

Practical use tips (to get the best from treatment)

• Set reminders: Use a phone alarm, calendar reminders, or a pill organiser.
• Keep a regular routine: Link your dose to a daily habit (breakfast, brushing teeth, bedtime).
• Use the right measuring method for oral solution: Measure carefully using the device provided by the pharmacist. Do not use household teaspoons.
• Stay hydrated and follow advice for kidney health: If you have kidney issues, avoid dehydration and discuss any “over-the-counter” NSAID use with your pharmacist.
• Attend follow-ups: Viral suppression and liver monitoring depend on scheduled blood tests.
• Keep an up-to-date medicine list: Include all prescription medicines, over-the-counter medicines, and supplements when speaking to healthcare professionals.

Alternative options (depending on the condition and guidance)

Alternative medicines may be considered depending on whether you are treated for HIV or hepatitis B, and on resistance patterns and overall health. Your clinician will decide the best option.

For HIV

Epivir is one NRTI option. Many HIV regimens use combinations of different antiretroviral medicines, sometimes including other NRTIs or medicines from different classes. The choice depends on viral resistance, pregnancy plans, kidney function, and interaction considerations.

For hepatitis B

For chronic hepatitis B, guidelines often prefer medicines with a high barrier to resistance for long-term use. Which agent is best can depend on treatment history, viral replication levels, and liver staging.

If you are switching from lamivudine or considering an alternative, it is important to follow a planned strategy to avoid viral rebound or liver flare.

Market and legal context in the United Kingdom

In the UK, medicines like Epivir are regulated under the Medicines and Healthcare products Regulatory Agency (MHRA) framework. Availability is managed through licensed manufacturers and supply chains, and products may be supplied by community pharmacies or via hospital services depending on the indication and local commissioning arrangements.

National clinical guidance for HIV and hepatitis B is issued and updated by specialist bodies and health services. Clinicians base treatment decisions on evidence and on the latest recommendations regarding best practice and resistance management.

Recent guidance and treatment principles (overview)

Treatment for HIV and hepatitis B evolves as new evidence becomes available. In recent years, guidance has generally emphasised:

• Combination therapy for HIV to maintain viral suppression and reduce resistance.
• Choosing effective hepatitis B treatments with consideration of resistance over time and patient-specific factors.
• Monitoring (viral load, liver enzymes, and kidney function) to identify problems early.
• Support for adherence (reminders, simplifying regimens when possible, and reviewing side effects).

Your healthcare team will interpret guidance for your individual circumstances.

Delivery and availability (UK)

Epivir may be available through UK pharmacies and approved online pharmacy services, depending on stock and formulation (tablets vs oral solution). Delivery times can vary by location and supplier.

• Check product availability: If a specific pack size or formulation is temporarily out of stock, your supplier may offer alternatives.
• Address accuracy: Ensure your delivery address is complete to avoid delays.
• Packaging: Medicines are typically supplied in tamper-evident packaging.
• Storage on arrival: Store according to the leaflet or label instructions.

If you need urgent medication, choose a supplier/service that clearly states delivery options and cut-off times at checkout.

Frequently asked questions (FAQ)

1) What is Epivir used for?

Epivir (lamivudine) is used to treat HIV infection as part of combination therapy and to treat chronic hepatitis B in selected patients.

2) Can I take Epivir with food?

Usually, yes. Epivir can generally be taken with or without food. If you experience stomach upset, taking it with meals may help.

3) What should I do if I miss a dose?

Take the missed dose as soon as you remember unless it’s almost time for your next dose. Do not take a double dose to make up for the missed one.

4) Is Epivir safe for people with kidney problems?

Lamivudine is cleared through the kidneys. If you have reduced kidney function, your clinician may adjust the dose and monitor you more closely. Do not adjust dosing yourself.

5) Can I drink alcohol while taking Epivir?

Alcohol may not have a direct interaction with lamivudine, but it can affect your health—especially if you have hepatitis B. If you’re unsure, ask your healthcare professional what level of alcohol intake is safest for you.

6) Does Epivir interact with other medicines?

Potential interactions can occur, especially because lamivudine is eliminated by the kidneys and because you may be taking other antivirals. It’s important to review your full medicine list with a pharmacist or clinician.

7) What side effects are common?

Common side effects include nausea, headache, fatigue, and diarrhoea. Many are mild, but if symptoms persist or worsen, speak to a healthcare professional.

8) Are there any serious warning signs?

Seek urgent medical advice if you develop signs of serious allergic reaction, significant liver problems (particularly with hepatitis B), or symptoms suggestive of lactic acidosis (rare but serious). When in doubt, err on the side of seeking advice promptly.

9) How long will I need to take it?

For HIV, treatment is often long-term. For hepatitis B, duration depends on your response and whether treatment goals are being met. Your specialist will advise a plan tailored to you.

10) What if I stop taking Epivir?

Do not stop abruptly without medical advice. In hepatitis B, stopping can cause a flare of liver disease. In HIV, stopping can risk loss of viral control.

11) Is Epivir available in different forms?

Epivir may be supplied as tablets and as an oral solution. Availability depends on local stock and the formulation required.

12) Can children take Epivir?

Lamivudine dosing for children may be weight-based and usually requires careful selection of the formulation (often oral solution). A clinician should determine the correct dose and schedule.

Important: This information is for guidance only and does not replace personalised medical advice. If you have questions about whether Epivir is suitable for you, how to take it, or how to manage side effects, speak to a qualified healthcare professional.